[go: up one dir, main page]

TW200800978A - Carbazole compound - Google Patents

Carbazole compound

Info

Publication number
TW200800978A
TW200800978A TW096108914A TW96108914A TW200800978A TW 200800978 A TW200800978 A TW 200800978A TW 096108914 A TW096108914 A TW 096108914A TW 96108914 A TW96108914 A TW 96108914A TW 200800978 A TW200800978 A TW 200800978A
Authority
TW
Taiwan
Prior art keywords
diseases
carbazole compound
salt
tract diseases
hydrogen atom
Prior art date
Application number
TW096108914A
Other languages
English (en)
Inventor
Takeshi Kuroda
Takahito Yamauchi
Tomoichi Shinohara
Kunio Oshima
Chiharu Kitajima
Hitoshi Nagao
Hironobu Ishiyama
Kazuhide Ohta
Masaaki Takano
Takumi Sumida
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of TW200800978A publication Critical patent/TW200800978A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW096108914A 2006-03-23 2007-03-15 Carbazole compound TW200800978A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006080451 2006-03-23

Publications (1)

Publication Number Publication Date
TW200800978A true TW200800978A (en) 2008-01-01

Family

ID=38171158

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096108914A TW200800978A (en) 2006-03-23 2007-03-15 Carbazole compound

Country Status (3)

Country Link
AR (1) AR059969A1 (zh)
TW (1) TW200800978A (zh)
WO (1) WO2007119600A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2576536B1 (en) * 2010-06-01 2016-09-14 The University of Queensland Haematopoietic-prostaglandin d2 synthase inhibitors
EP3321264A1 (en) * 2016-11-14 2018-05-16 Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft Selective inhibitors of genotoxic stress-induced ikk/nf-kb pathways
BR112019025797A2 (pt) * 2017-06-05 2020-07-07 National University Of Singapore compostos úteis na inibição do fator trefoil 3 humano
CN107698579B (zh) * 2017-11-23 2019-11-08 广东工业大学 一种咔唑衍生物、其制备方法及在抗肿瘤中的应用
WO2024079677A1 (en) * 2022-10-15 2024-04-18 Pillai Universal Llc Novel therapeutic molecule

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2381397A (en) * 1996-04-19 1997-11-12 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
JP3812772B2 (ja) * 1997-10-03 2006-08-23 富士写真フイルム株式会社 熱現像感光材料
BR0212522A (pt) * 2001-09-14 2004-08-10 Novo Nordisk As Ligando de ligação de zinco, hexâmero de insulina, preparação aquosa de insulina e métodos de prolongar a ação de uma preparação de insulina e de preparar um ligando de ligação de zinco
JP2003264010A (ja) * 2002-03-07 2003-09-19 Mitsubishi Paper Mills Ltd 光電変換素子
EP2009064B1 (en) * 2002-07-29 2012-10-24 Mitsubishi Paper Mills Limited Organic dye, photoelectric transducing material, semiconductor electrode, and photoelectric transducing device
AU2003291972A1 (en) * 2002-12-20 2004-07-14 Novo Nordisk A/S Pharmaceutical compositions comprising insulin and legends of insulin hexamer
EP1768694A1 (en) * 2004-07-09 2007-04-04 Novo Nordisk A/S Phamaceutical preparations comprising insulin

Also Published As

Publication number Publication date
AR059969A1 (es) 2008-05-14
WO2007119600A9 (en) 2008-05-02
WO2007119600A1 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
TW200616961A (en) Carbostyril compound
MX2010002820A (es) Analogos de tiazolidindiona para tratamiento de hipertension.
WO2007095174A3 (en) Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions
UA93872C2 (ru) Дигидротиенопиримидины для лечения воспалительных заболеваний
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
WO2008019967A3 (en) Phenyl, pyridine and quinoline derivatives
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
MY149648A (en) Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
MX2010009752A (es) Compuestos de oxadiazoantraceno para el tratamiento de diabetes.
IN2012DN00869A (zh)
TW200740760A (en) Malonamide derivatives
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
TW200612936A (en) Indole derivatives
MX2009012125A (es) Compuestos terapeuticos.
MXPA06009475A (es) Derivados de quinazolina y usos terapeuticos de los mismos.
IL194057A0 (en) Pyrimidine, quinazoline, pteridine and triazine derivatives
TW200716547A (en) Piperidin-4-yl-amide derivatives
TW200800978A (en) Carbazole compound
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
IL195747A0 (en) Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity
TW200626158A (en) Naphthaline derivatives
MY158069A (en) Tricyclic compound and pharmaceutical use thereof
MX2009013775A (es) Sustituto novedoso de piperidones sustituidas como inductor de hsp.
PT1745010E (pt) Derivados de ciclo-hexil-1,4-diamina substituídos